Amerant Bancorp (AMTB)
(Delayed Data from NYSE)
$21.58 USD
-0.50 (-2.26%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $21.55 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Amerant Bancorp Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 636 | 406 | 368 | 334 | 370 |
Cost Of Goods | 184 | 49 | 28 | 53 | 68 |
Gross Profit | 452 | 357 | 341 | 281 | 302 |
Selling & Adminstrative & Depr. & Amort Expenses | 373 | 255 | 182 | 267 | 206 |
Income After Depreciation & Amortization | 80 | 102 | 159 | 13 | 96 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 38 | 23 | 15 | 18 | 32 |
Pretax Income | 41 | 79 | 144 | -4 | 64 |
Income Taxes | 11 | 17 | 34 | -3 | 13 |
Minority Interest | -2 | -1 | -3 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 31 | 62 | 110 | -2 | 51 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 32 | 63 | 113 | -2 | 51 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 91 | 116 | 179 | 38 | 117 |
Depreciation & Amortization (Cash Flow) | 12 | 14 | 20 | 24 | 21 |
Income After Depreciation & Amortization | 80 | 102 | 159 | 13 | 96 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 33.68 | 34.14 | 37.53 | 41.74 | 42.94 |
Diluted EPS Before Non-Recurring Items | 1.93 | 2.12 | 1.78 | 0.09 | 1.24 |
Diluted Net EPS (GAAP) | 0.96 | 1.85 | 3.01 | -0.04 | 1.20 |
Fiscal Year end for Amerant Bancorp Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 165.18 | 161.30 | 165.12 | 144.47 |
Cost Of Goods | NA | 55.28 | 50.20 | 44.64 | 33.62 |
Gross Profit | NA | 109.90 | 111.11 | 120.47 | 110.86 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 122.20 | 72.43 | 101.58 | 76.43 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -12.30 | 38.68 | 18.89 | 34.43 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 8.61 | 10.61 | 9.98 | 9.18 |
Pretax Income | NA | -20.91 | 28.08 | 8.92 | 25.24 |
Income Taxes | NA | -2.97 | 6.34 | 1.87 | 5.30 |
Minority Interest | NA | -0.82 | -0.38 | -0.26 | -0.24 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -17.94 | 21.74 | 7.05 | 19.94 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -17.12 | 22.12 | 7.31 | 20.19 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 33.43 | 33.70 | 33.72 | 33.86 |
Diluted EPS Before Non-Recurring Items | NA | 0.46 | 0.64 | 0.24 | 0.59 |
Diluted Net EPS (GAAP) | NA | -0.52 | 0.66 | 0.22 | 0.60 |